​

Foghorn Therapeutics Ownership | Who Owns Foghorn Therapeutics?

OverviewForecastRevenueFinancialsChart

Foghorn Therapeutics Ownership Summary

Foghorn Therapeutics is owned by 13.24% institutional investors, 18.03% insiders, and 68.73% retail investors. Flagship pioneering is the largest institutional shareholder, holding 20.12% of FHTX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 4.73% of its assets in Foghorn Therapeutics shares.

FHTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockFoghorn Therapeutics13.24%18.03%68.73%
SectorHealthcare Stocks 232.80%10.63%-143.43%
IndustryBiotech Stocks 379.48%10.37%-289.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Flagship pioneering12.67M20.12%$60.58M
Fmr6.05M9.60%$28.91M
Bvf inc/il5.84M9.28%$27.92M
Deerfield management company, l.p. (series c)4.39M6.98%$21.01M
Raymond james & associates2.34M5.51%$13.45M
Raymond james financial2.60M4.13%$12.44M
Blackrock funding, inc. /de2.36M3.75%$11.30M
Blackrock1.55M3.64%$8.89M
Vanguard group1.93M3.06%$10.42M
Euclidean capital1.57M2.50%$7.52M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Flagship pioneering12.67M5.22%$60.58M
Euclidean capital1.57M1.92%$7.52M
Bvf inc/il5.84M0.89%$27.92M
Birchview capital, lp281.73K0.77%$1.35M
B group102.00K0.36%$487.56K
Deerfield management company, l.p. (series c)4.39M0.25%$21.01M
Verdad advisers, lp24.42K0.13%$116.71K
Dafna capital management111.86K0.12%$534.69K
Artal group720.72K0.11%$4.14M
Siren720.72K0.10%$3.45M

Top Buyers

HolderShares% AssetsChange
Deerfield management company, l.p. (series c)4.39M0.25%745.16K
Fmr6.05M0.00%650.38K
Bvf inc/il5.84M0.89%540.00K
Candriam s.c.a.313.76K0.01%313.76K
Vanguard fiduciary trust240.59K0.00%240.59K

Top Sellers

HolderShares% AssetsChange
Driehaus capital management---568.47K
Perceptive advisors---544.00K
Alphabet---500.90K
Millennium management29.55K0.00%-179.01K
Ameriprise financial448.98K0.00%-158.69K

New Positions

HolderShares% AssetsChangeValue
Candriam s.c.a.313.76K0.01%313.76K$1.50M
Vanguard fiduciary trust240.59K0.00%240.59K$1.15M
Readystate asset management lp161.14K0.03%161.14K$787.98K
B group102.00K0.36%102.00K$487.56K
Verdad advisers, lp24.42K0.13%24.42K$116.71K

Sold Out

HolderChange
Ifp advisors-2.00
Zurcher kantonalbank (zurich cantonalbank)-2.00
Nelson, van denburg & campbell wealth management group-3.00
Capital performance advisors llp-14.00
Visionpoint advisory group-210.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202549-43.68%8,344,333-79.60%130.31%23-48.89%14-33.33%
Sep 30, 202549-33.78%13,088,757-67.93%200.49%21-52.27%1416.67%
Jun 30, 202578-10.34%40,954,5985.44%651.70%4528.57%14-51.72%
Mar 31, 2025883.53%40,415,6380.43%641.56%35-27.08%29163.64%
Dec 31, 202436-55.00%7,752,816-80.62%120.30%22-46.34%2-89.47%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O2.62M4.73%-
Fidelity Growth Compy Commingled Pl S2.72M4.63%3.28K
Fidelity Growth Company Fund1.84M3.13%-
Vanguard Total Stock Mkt Idx Inv1.03M1.75%-
Vanguard US Total Market Shares ETF962.18K1.73%-
iShares Russell 2000 ETF759.21K1.29%6.39K
Fidelity Select Biotechnology654.28K1.11%-
Fidelity Growth Company K6504.26K0.86%-3.28K
Vanguard Institutional Extnd Mkt Idx Tr429.78K0.73%65.38K
Fidelity Small Cap Index327.57K0.56%-1.33K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 23, 2024Costa Carlos Chief People OfficerSell$8.72K
Sep 20, 2024Costa Carlos Chief People OfficerSell$358.99K
Sep 18, 2024Costa Carlos Chief People OfficerSell$116.32K
Sep 16, 2024Costa Carlos Chief People OfficerSell$4.00K
Sep 17, 2024Costa Carlos Chief People OfficerSell$103.13K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q4--
2025 Q2--
2025 Q1--
2024 Q4--

FHTX Ownership FAQ

Who Owns Foghorn Therapeutics?

Foghorn Therapeutics shareholders are primarily institutional investors at 13.24%, followed by 18.03% insiders and 68.73% retail investors. The average institutional ownership in Foghorn Therapeutics's industry, Biotech Stocks , is 379.48%, which Foghorn Therapeutics falls below.

Who owns the most shares of Foghorn Therapeutics?

Foghorn Therapeutics’s largest shareholders are Flagship pioneering (12.67M shares, 20.12%), Fmr (6.05M shares, 9.60%), and Bvf inc/il (5.84M shares, 9.28%). Together, they hold 39.00% of Foghorn Therapeutics’s total shares outstanding.

Does Blackrock own Foghorn Therapeutics?

Yes, BlackRock owns 3.64% of Foghorn Therapeutics, totaling 1.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.89M$. In the last quarter, BlackRock increased its holdings by 230.7K shares, a 17.54% change.

Who is Foghorn Therapeutics’s biggest shareholder by percentage of total assets invested?

Flagship pioneering is Foghorn Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.22% of its assets in 12.67M Foghorn Therapeutics shares, valued at 60.58M$.

Who is the top mutual fund holder of Foghorn Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Foghorn Therapeutics shares, with 4.73% of its total shares outstanding invested in 2.62M Foghorn Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools